- Home
- PFS vs CNTA Comparison
PFS vs CNTA Comparison
Compare PFS & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFS
- CNTA
- Stock Information
- Founded
- PFS 1839
- CNTA 2020
- Country
- PFS United States
- CNTA United Kingdom
- Employees
- PFS N/A
- CNTA N/A
- Industry
- PFS Savings Institutions
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PFS Finance
- CNTA Health Care
- Exchange
- PFS Nasdaq
- CNTA Nasdaq
- Market Cap
- PFS 2.4B
- CNTA 2.0B
- IPO Year
- PFS N/A
- CNTA 2021
- Fundamental
- Price
- PFS $17.83
- CNTA $15.73
- Analyst Decision
- PFS Strong Buy
- CNTA Strong Buy
- Analyst Count
- PFS 4
- CNTA 7
- Target Price
- PFS $20.25
- CNTA $23.14
- AVG Volume (30 Days)
- PFS 724.3K
- CNTA 1.1M
- Earning Date
- PFS 10-29-2024
- CNTA 11-11-2024
- Dividend Yield
- PFS 5.36%
- CNTA N/A
- EPS Growth
- PFS N/A
- CNTA N/A
- EPS
- PFS 0.93
- CNTA N/A
- Revenue
- PFS $427,771,000.00
- CNTA $6,853,000.00
- Revenue This Year
- PFS N/A
- CNTA N/A
- Revenue Next Year
- PFS $27.22
- CNTA N/A
- P/E Ratio
- PFS $19.32
- CNTA N/A
- Revenue Growth
- PFS N/A
- CNTA N/A
- 52 Week Low
- PFS $13.07
- CNTA $5.33
- 52 Week High
- PFS $19.59
- CNTA $17.59
- Technical
- Relative Strength Index (RSI)
- PFS 44.40
- CNTA 53.46
- Support Level
- PFS $17.42
- CNTA $15.37
- Resistance Level
- PFS $18.71
- CNTA $17.44
- Average True Range (ATR)
- PFS 0.50
- CNTA 0.92
- MACD
- PFS -0.13
- CNTA -0.15
- Stochastic Oscillator
- PFS 19.71
- CNTA 16.52
About PFS Provident Financial Services Inc
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.